A detailed history of Harbour Investments, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Harbour Investments, Inc. holds 616 shares of BDX stock, worth $136,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares
616
Previous 538 14.5%
Holding current value
$136,690
Previous $125,000 18.4%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$221.47 - $242.41 $17,274 - $18,907
78 Added 14.5%
616 $148,000
Q2 2024

Jul 26, 2024

SELL
$225.07 - $246.17 $10,353 - $11,323
-46 Reduced 7.88%
538 $125,000
Q1 2024

Jul 22, 2024

BUY
$233.45 - $247.73 $10,972 - $11,643
47 Added 8.75%
584 $144,000
Q4 2023

Feb 16, 2024

SELL
$232.24 - $267.23 $207,158 - $238,369
-892 Reduced 62.42%
537 $130,000
Q3 2023

Nov 15, 2023

BUY
$254.9 - $283.59 $24,980 - $27,791
98 Added 7.36%
1,429 $369,000
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $9,058 - $10,082
38 Added 2.94%
1,331 $351,000
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $4,594 - $5,187
-20 Reduced 1.52%
1,293 $320,000
Q4 2022

Feb 15, 2023

BUY
$218.29 - $256.91 $17,244 - $20,295
79 Added 6.4%
1,313 $334,000
Q2 2022

Aug 15, 2022

BUY
$234.74 - $275.42 $4,694 - $5,508
20 Added 1.65%
1,234 $304,000
Q4 2021

Feb 16, 2022

SELL
$230.08 - $250.94 $86,049 - $93,851
-374 Reduced 23.55%
1,214 $305,000
Q3 2021

Nov 15, 2021

SELL
$232.72 - $256.47 $61,903 - $68,221
-266 Reduced 14.35%
1,588 $390,000
Q2 2021

Aug 16, 2021

BUY
$232.65 - $254.58 $65,607 - $71,791
282 Added 17.94%
1,854 $451,000
Q1 2021

Aug 17, 2021

BUY
$232.09 - $256.88 $324,461 - $359,118
1,398 Added 803.45%
1,572 $382,000
Q1 2021

May 12, 2021

BUY
$232.09 - $256.88 $40,383 - $44,697
174 New
174 $42,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.